A cell therapy
product for alleviating symptoms and signs of ischemia
with peripheral arterial disease (PAD)
and coronary artery disease (CAD).
A biosynthetic vascular graft providing improved biocompatibility for PAD patients undergoing bypass surgery and for renal disease patients who need an access site for hemodialysis.